July 22, 2026 a 11:43 am
VTRS: Fundamental Ratio Analysis - Viatris Inc.
Viatris Inc., with its wide-ranging pharmaceutical portfolio and global presence, provides promising potential in the healthcare market. However, the stock's fundamental ratios suggest caution, with a need to carefully consider the company's low scores in return on equity and assets despite its significant DCF valuation. This entails potential risks which investors should weigh against the broader industry dynamics.
Fundamental Rating
The current fundamental data suggests moderate performance, indicated by a C+ rating for Viatris Inc. The company's strengths in discounted cash flow are counterbalanced by weaker returns on equity and assets.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 1 | |
| Return on Assets | 1 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 4 |
Historical Rating
A comparison of the current and past ratings reflects stable scores in fundamental metrics over time, with minimal change in overall performance.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-07-21 | 2 | 4 | 1 | 1 | 1 | 1 | 4 |
| Previous | 0 | 4 | 1 | 1 | 1 | 1 | 4 |
Analyst Price Targets
The analyst consensus indicates a conservative hold stance, with expected price targets indicating a considerable spread between high and low estimates, reinforcing market uncertainty regarding Viatris's future stock performance.
| High | Low | Median | Consensus |
|---|---|---|---|
| $22 | $12 | $19 | $18 |
Analyst Sentiment
The predominant 'Hold' sentiment among analysts suggests a cautious approach, with limited enthusiasm for significant gains despite existing buy positions.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 4 | |
| Hold | 8 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Viatris Inc. showcases a robust portfolio in the pharmaceutical sector, with a commendable presence across multiple therapeutic areas. However, fundamental indicators highlight challenges in certain metrics, which could present potential risks. Analyst ratings and price targets provide a cautious outlook, suggesting a stable yet uncertain growth trajectory. Investors may find opportunities in Viatris's strategic collaborations and innovative ventures, but should remain vigilant of market dynamics and company-specific risks.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years